Loading
collectionsCollection
Melanoma Research Alliance (MRA)
A melanoma research funder created in 2007 by the Milken family that backed early immunotherapy and targeted-therapy work and now focuses on rare melanoma subtypes and resistance.
Overview
Founded 2007 (Debra and Leon Black with Michael Milken); 100% of donations go to research thanks to founders covering overhead. Funded early research on PD-1, BRAF/MEK combinations, neoadjuvant immunotherapy and TIL therapy; runs the RARE patient registry for acral and mucosal melanoma, the Dermatology Fellowship programme, and patient education on adjuvant and neoadjuvant choices. Partners with industry via the Melanoma Research Alliance Team Science Awards.
Holds
The largest private funder of melanoma research (>$150 million), patient and caregiver resources, the RARE Registry for acral and mucosal melanoma, and the annual scientific retreat.
Licence
Copyright MRA
Maintainer
MRA
Similar pages
- PersonDebra Black
Shares Melanoma Research Alliance, Melanoma.
- JournalMelanoma research
Shares Uveal melanoma, Melanoma.
- JournalPigment cell & melanoma research
Shares Uveal melanoma, Melanoma.
- PersonPamela S. Ohashi
Shares TIL therapy, Melanoma.
- PersonLeon Black
Shares Melanoma Research Alliance, Melanoma.
- PairingPD-1 failure → TIL therapy
Shares TIL therapy, Melanoma.
- TrialA Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Shares Uveal melanoma, Melanoma.
- PersonShari Pilon-Thomas
Shares TIL therapy, Melanoma.